Cempra to Present at Three Upcoming Investor Conferences

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cempra to Present at Three Upcoming Investor Conferences

CHAPEL HILL, N.C., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq: CEMP ), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced it will be participating in three upcoming investor conferences.

  • Baird Global Healthcare Conference - 2016, The New York Palace Hotel, New York, September 8, 2016 at 3:10 p.m. EDT.
  • Morgan Stanley Global Healthcare Conference, the Grand Hyatt Hotel, New York, September 12, 2016 at 1:05 p.m. EDT.
  • Ladenburg Thalmann 2016 Healthcare Conference, Sofitel Hotel, New York, September 27, 2016 at 12:00 p.m. EDT

A live audio webcast and archive of the presentations will be available on the company website at http://investor.cempra.com/events.cfm . Listeners are encouraged to visit the site prior to the scheduled presentation to register, download and install any necessary audio software.

About Cempra, Inc.

Cempra, Inc. is a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases. Cempra's two lead product candidates are currently in advanced clinical development. Solithromycin has been successfully evaluated in two Phase 3 clinical trials for community acquired bacterial pneumonia (CABP) and applications for approval for both intravenous and oral capsule formulations have been accepted for review by the FDA and the EMA. Solithromycin is licensed to strategic commercial partner Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation, for certain exclusive rights in Japan. Solithromycin is also in a Phase 3 clinical trial for uncomplicated urogenital urethritis caused by Neisseria gonorrhoeae or chlamydia. Cempra is contracted with BARDA for the development of solithromycin for pediatric use. Three formulations, intravenous, oral capsules and a suspension formulation are in a Phase 1b trial in children from birth to 17 years of age. Fusidic acid is Cempra's second product candidate, which is being developed for acute bacterial skin and skin structure Infections (ABSSSI) and is also in an exploratory study for chronic oral treatment of refractory infections in bones and joints. Both products seek to address the need for new treatments targeting drug-resistant bacterial infections in the hospital and in the community. Cempra has also synthesized novel macrolides for non-antibiotic uses such as the treatment of chronic inflammatory diseases, endocrine diseases and gastric motility disorders. Cempra was founded in 2006 and is headquartered in Chapel Hill, N.C. For additional information about Cempra please visit www.cempra.com .

Company Contact: John Bluth Cempra, Inc. +1 984 209 4534 jbluth@cempra.com  Investor Contact: Robert Uhl Westwicke Partners, LLC +1 858 356 5932 robert.uhl@westwicke.com  Media Contact: Melyssa Weible Elixir Health PR +1 201 723 5805 mweible@elixirhealthpr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 49

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Virginia Cancer Specialists: Leaders in Trusted Cancer Care

Updated Category News Views 69

Decades of Trust in Cancer Care Virginia Cancer Specialists isn't just another name in the sea of healthcare providers. That pride they're feeling? Well, they've got every right to it. Just slapped their physicians' names all over the latest Washingtonian's Top Doctors list for 2026. And this isn’t some under-the-table handshake deal. No, this list is shaped by peer...

Continue Reading
Heart Failure Certification Highlights Quality at Two Centers

Updated Category News Views 55

Celebrating Milestones in Healthcare Certification Out there in the Bronx, two skilled nursing facilities just snagged a certification that means they're playing in the big leagues of heart failure care. Holliswood Center and Bushwick Center, both under the Centers Health Care umbrella, have been awarded the Skilled Nursing Facility Heart Failure Certification from none...

Continue Reading
Radiation Oncologist Dr. Pennock Honored: A Closer Look

Updated Category News Views 56

An Honor from The Inner Circle Sometimes, in a field stuffed with brilliant minds, a beacon stands out. That's Dr. Michael M. Pennock for you—a man who doesn’t just treat cancer patients but transforms their journeys with precision and empathy. Recognized as a Pinnacle Lifetime Member by The Inner Circle, Pennock’s dedication in the field of radiation oncology is...

Continue Reading
California Cash Surplus Raises Investor Eyebrows

Updated Category News Views 44

California's Unexpected Financial Bounty Kicking things off with a real humdinger: California's September cash flow exceeded expectations by a whopping $2.9 billion. That's not chump change, folks. It's like finding an extra twenty in your coat pocket but on a much grander scale. Impressively, the state's General Fund receipts tallied up to $22.9 billion, surpassing the...

Continue Reading
Miracle League Marks Two Decades with Big Fundraising Win

Updated Category News Views 66

A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...

Continue Reading
Ruizhi Unveils Trio of High-Tech Paper Bag Machines

Updated Category News Views 0

Cutting-Edge Unveiling at All in Print China 2026 In the bustling expo halls of the Shanghai New International Expo Centre, Ruizhi Machinery rolled out the red carpet for its latest inventions, stealing the limelight at the All in Print China 2026. Now, these were not your run-of-the-mill paper bag makers; we're talking about a set of machines that could redefine the gig...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 117

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Global Photo Contest Highlights Wetland Wonders

Updated Category News Views 50

Sparking Global Dialogue Through Photography Ever thought a photo could spark a conversation across continents? That's exactly what's happening with the 2026 Nandagang International Wetland Photo Contest. This ain't just any photo op—it's a call to action, a rallying cry using the beauty of nature to highlight the urgency of wetland conservation. From Local to Global:...

Continue Reading
Xyte's Record Quarter: Surging Demand & New CEO

Updated Category News Views 30

Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...

Continue Reading

Top 5 Most Recently Viewed Articles

Future Growth of Edge AI Hardware: Trends and Insights

Updated Category News Views 184

The Expanding Edge AI Hardware Market The edge AI hardware market is on the brink of substantial growth, with projections indicating it will reach approximately USD 58.90 billion by the end of the decade. This growth is anticipated to accelerate from its current estimated value of USD 26.14 billion, showcasing an impressive compound annual growth rate (CAGR) of 17.6%. One...

Continue Reading
Orex Minerals Achieves Significant Gold-Silver Drill Results

Updated Category News Views 202

Exciting Gold-Silver Drilling Results at Coneto Orex Minerals Inc. has announced strong developments from its ongoing exploration efforts on the Coneto Gold-Silver Project. The company reported exceptional findings during the recently completed Phase-VI diamond drilling program that spanned over 2,000 metres across 8 drill holes. Highlighting the Loma Verde Vein The Loma...

Continue Reading
How Geopolitical Tensions and US Inflation Impact the Dollar

Updated Category News Views 191

Geopolitical Factors and the US Dollar In today's financial landscape, geopolitical events often capture more attention than traditional economic data, particularly in the case of the US dollar. Recent developments indicate that tensions around geopolitical issues could overshadow crucial US economic data. As traders and investors respond to these external factors, the...

Continue Reading
Polaris Renewable Energy's Q3 2024 Earnings: Performance Insights

Updated Category News Views 283

Polaris Renewable Energy Reports Q3 2024 Financial Results Polaris Renewable Energy Incorporated (TSX:PIF), a prominent player in the renewable energy sector, recently revealed its financial performance for the third quarter of 2024. The company experienced a reduction in power generation and revenue compared to the previous year. This decline saw production minimize to...

Continue Reading
Key Insights from Putin's Recent Annual News Conference

Updated Category News Views 114

Key Insights from Putin's Recent Annual News Conference During a noteworthy annual news conference, Russian President Vladimir Putin shared crucial insights that sparked attention on various international fronts. On Russia's Military Advances In discussing the new Oreshnik hypersonic missile, Putin confidently stated, "There is no chance of shooting down these missiles."...

Continue Reading